ml 23 has been researched along with oxidopamine in 2 studies
| Studies (ml 23) | Trials (ml 23) | Recent Studies (post-2010) (ml 23) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | ml 23 (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kennedy, GA; Willis, GL | 1 |
| Robertson, AD; Willis, GL | 1 |
1 review(s) available for ml 23 and oxidopamine
| Article | Year |
|---|---|
The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease.
Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; Humans; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Rotation; Time | 2004 |
1 other study(ies) available for ml 23 and oxidopamine
| Article | Year |
|---|---|
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.
Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Recovery of Function | 2004 |